Drug Type Recombinant LBP |
Synonyms Labafenogene marselecobac |
Target |
Mechanism PheP stimulants(Phenylalanine transporter stimulants), mPAL stimulants(phenylalanine ammonia lyase stimulants), Bacteria replacements + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Phenylketonurias | Phase 3 | CA | 05 Jul 2023 | |
Phenylketonurias | Phase 3 | TR | 05 Jul 2023 | |
Phenylketonurias | Phase 3 | GE | 05 Jul 2023 | |
Phenylketonurias | Phase 3 | US | 05 Jul 2023 |
Phase 3 | 35 | (DEP (Part 1, SYNB1934v1)) | muxaowfkuz(suvelfoakp) = qhcwjizsyn otmorampnj (lwgnwdqpmg, eogzmyiinm - trjaxnveke) View more | - | 20 Jun 2024 | ||
(RWP (Part 2, SYNB1934v1)) | muxaowfkuz(suvelfoakp) = xgdcceygvs otmorampnj (lwgnwdqpmg, oqxxwuqfnb - nhwfiggtnk) View more |